Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Early research (Phase 1)Study completedNCT02201303
What this trial is testing

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Very early researchStudy completedNCT05148780
What this trial is testing

Acute Respiratory Infections in Global Outpatient Setting

Who this might be right for
Acute Respiratory Infection
Janssen Research & Development, LLC 245
Early research (Phase 1)Study completedNCT06917508
What this trial is testing

Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

Who this might be right for
RSV InfectionDrug Drug Interaction
Enanta Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07717840
What this trial is testing

Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)

Who this might be right for
RSV Respiratory Syncytial Virus
AstraZeneca 164
Large-scale testing (Phase 3)Ended earlyNCT04583280
What this trial is testing

Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Tract Infections
Janssen Research & Development, LLC 28
Early research (Phase 1)Study completedNCT02298179
What this trial is testing

Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT02442427
What this trial is testing

"Palivizumab Therapy for RSV-bronchiolitis"

Who this might be right for
Respiratory Syncytial Virus-bronchiolitis
Hamad Medical Corporation 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Early research (Phase 1)Study completedNCT06601192
What this trial is testing

Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults

Who this might be right for
RSV InfectionQTc Interval
Enanta Pharmaceuticals, Inc 72
Testing effectiveness (Phase 2)Study completedNCT06097299
What this trial is testing

MRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 349
Not applicableStudy completedNCT02853838
What this trial is testing

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

Who this might be right for
Bronchiolitis, Viral
Universidad del Desarrollo 204
Early research (Phase 1)WithdrawnNCT02864628
What this trial is testing

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic
Large-scale testing (Phase 3)Study completedNCT02624947
What this trial is testing

Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 4,636
Early research (Phase 1)Study completedNCT03387137
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT02202356
What this trial is testing

ALS-008176 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 183
Large-scale testing (Phase 3)Ended earlyNCT06705140
What this trial is testing

A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 42
Next Page